Banner Alzheimer’s Institute Partners with Novartis in New Study of Alzheimer’s Prevention Treatments

Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs–an active immunotherapy and an oral medication–can prevent or delay the emergence of symptoms of Alzheimer’s in people at particularly high risk for developing the disease at older ages.Continue reading

New Council of International Biotech Associations Formed

Washington, D.C. (July 10, 2014) –An international confederation of biotechnology trade associations announced today the ratification of bylaws creating the International Council of Biotechnology Associations (ICBA), with the expressed purpose of advocating for public policies that support the growth of the innovative biotechnology industry worldwide.Continue reading

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

 Ventana Medical Systems, Inc.  (Ventana), a member of the Roche  Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA’s biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana’s proprietary diagnostic assays.Continue reading